291 related articles for article (PubMed ID: 29332347)
41. CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy.
Li J; Chen JN; Zeng TT; He F; Chen SP; Ma S; Bi J; Zhu XF; Guan XY
BMC Cancer; 2016 Jan; 16():15. PubMed ID: 26758620
[TBL] [Abstract][Full Text] [Related]
42. BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
Stem Cell Res Ther; 2019 Aug; 10(1):237. PubMed ID: 31387619
[TBL] [Abstract][Full Text] [Related]
43. Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney.
Liu N; Tian J; Cheng J; Zhang J
J Cell Biochem; 2013 Dec; 114(12):2677-89. PubMed ID: 23794207
[TBL] [Abstract][Full Text] [Related]
44. Protection of bone marrow-derived CD45+/CD34-/lin- stromal cells with immunosuppressant activity against ischemia/reperfusion injury in rats.
Chung YC; Ma MC; Huang BY; Chiang HS; Chou SH
Chin J Physiol; 2011 Jun; 54(3):169-82. PubMed ID: 21789899
[TBL] [Abstract][Full Text] [Related]
45. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
46. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ
World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-145 engineered bone marrow-derived mesenchymal stem cells alleviated erectile dysfunction in aged rats.
Liu Q; Cui Y; Lin H; Hu D; Qi T; Wang B; Huang Z; Chen J; Li K; Xiao H
Stem Cell Res Ther; 2019 Dec; 10(1):398. PubMed ID: 31852516
[TBL] [Abstract][Full Text] [Related]
48. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
49. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
[TBL] [Abstract][Full Text] [Related]
50. Advanced glycosylation end products inhibit the proliferation of bone-marrow stromal cells through activating MAPK pathway.
Li Z; Wang X; Hong TP; Wang HJ; Gao ZY; Wan M
Eur J Med Res; 2021 Aug; 26(1):94. PubMed ID: 34407888
[TBL] [Abstract][Full Text] [Related]
51. Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction.
Blondiaux E; Pidial L; Autret G; Rahmi G; Balvay D; Audureau E; Wilhelm C; Guerin CL; Bruneval P; Silvestre JS; Menasché P; Clément O
J Tissue Eng Regen Med; 2017 Dec; 11(12):3417-3427. PubMed ID: 28156084
[TBL] [Abstract][Full Text] [Related]
52. Transplantation of bone marrow-derived mesenchymal stem cells with silencing of microRNA-138 relieves pelvic organ prolapse through the FBLN5/IL-1β/elastin pathway.
Zhao B; Sun Q; Fan Y; Hu X; Li L; Wang J; Cui S
Aging (Albany NY); 2021 Jan; 13(2):3045-3059. PubMed ID: 33460398
[TBL] [Abstract][Full Text] [Related]
53. [Effect of bone marrow stromal cells transfected with interleukin 18 on growth of intracranial glioma in rats].
Li CH; Jiao BH
Ai Zheng; 2007 Jan; 26(1):38-43. PubMed ID: 17222365
[TBL] [Abstract][Full Text] [Related]
54. Lentiviral-mediated growth-associated protein-43 modification of bone marrow mesenchymal stem cells improves traumatic optic neuropathy in rats.
Zhu Q; Liu Z; Wang C; Nie L; He Y; Zhang Y; Liu X; Su G
Mol Med Rep; 2015 Oct; 12(4):5691-700. PubMed ID: 26238991
[TBL] [Abstract][Full Text] [Related]
55. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
[TBL] [Abstract][Full Text] [Related]
56. Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo.
Zhang J; Hou L; Wu X; Zhao D; Wang Z; Hu H; Fu Y; He J
Mol Cell Biochem; 2016 May; 416(1-2):193-203. PubMed ID: 27142531
[TBL] [Abstract][Full Text] [Related]
57. Mig-6 is down-regulated in HCC and inhibits the proliferation of HCC cells via the P-ERK/Cyclin D1 pathway.
Li Z; Qu L; Luo W; Tian Y; Zhai H; Xu K; Zhong H
Exp Mol Pathol; 2017 Jun; 102(3):492-499. PubMed ID: 28506767
[TBL] [Abstract][Full Text] [Related]
58. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
[TBL] [Abstract][Full Text] [Related]
59. Magnetic Resonance Gd-RGD Imaging Study of Hepatocellular Carcinoma with High and Low Metastatic Potential before and after Human Bone Marrow-derived Mesenchymal Stem Cell Intervention.
Li TR; Yu MH; Huang XB; Yang ZJ; Lu GM; Li YJ
Chin Med J (Engl); 2017 Nov; 130(21):2591-2600. PubMed ID: 29067958
[TBL] [Abstract][Full Text] [Related]
60. [Role of neutrophils in treatment of rats with D-galactosamine-induced acute liver failure with bone marrow mesenchymal stem cells].
Zhao X; Shi XL; Zhang ZH; Ma HC; Yuan XW; Ding YT
Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):601-607. PubMed ID: 27788708
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
